NICE rejection leaves asbestos patients with no active treatment, says Cancerbackup

Reacting to the National Institute of Health and Clinical Excellence's (NICE) new interim guidance following the original negative decision upheld at appeal on Pemetrexed (Alimta) for the treatment of patients with mesothelioma, the condition caused by exposure to asbestos, charity Cancerbackup issues the following statement:

"Again it would seem that NICE is rejecting this drug largely on cost grounds", says Joanne Rule, chief executive of Cancerbackup. "But this treatment is for a disease which people have contracted mostly due to their working environment. It is not fair to deny active treatment to these patients. Although the drug is not curative it does offer extra months for a particularly vulnerable group of people with cancer. As this is the interim guidance until the final decision is issued by NICE, primary care trusts can and should make this treatment available to NHS patients under the Health Service Circular 1999/176."

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Stopping work transfer from hospitals tops list of GP demands to tackle workload

Stopping work transfer from hospitals tops list of GP demands to tackle workload

Stopping hospitals dumping tasks on general practice tops a list of measures GPs...

New NHS chief must seize opportunity to ‘reset relationship’ with GPs, BMA warns

New NHS chief must seize opportunity to ‘reset relationship’ with GPs, BMA warns

NHS England has the perfect opportunity to ‘reset its relationship’ with general...

GPs able to deliver flu jabs from other surgeries within PCN under new ES

GPs able to deliver flu jabs from other surgeries within PCN under new ES

GP surgeries who deliver flu jabs at PCN level this year will be treated as a ‘temporary...

Professor Dame Clare Gerada elected RCGP president

Professor Dame Clare Gerada elected RCGP president

London GP Professor Dame Clare Gerada will become the new president of the RCGP,...

GPs lead COVID-19 vaccine drive as jabs stall in younger adults

GPs lead COVID-19 vaccine drive as jabs stall in younger adults

GPs have urged young people to come forward for COVID-19 vaccination with jab uptake...

GPs leading PCNs report heavy workload and limited impact from ARRS

GPs leading PCNs report heavy workload and limited impact from ARRS

PCN clinical directors are facing burnout and struggling to develop their networks...